Fujirebio is a global R&D-driven company constantly developing new in vitro diagnostics (IVD) testing technologies and unique biomarkers with high clinical value.
We value our CDMO partnerships with many of the world’s leading diagnostic companies, sharing knowledge, capabilities, and critical materials to supply, develop, or manufacture diagnostic solutions on a wide variety of platforms.